Eligible patients with heart failure prescribed vs. not prescribed vericiguat in the United States

Eligible patients with heart failure prescribed vs. not prescribed vericiguat in the United States

AimsThis study compared characteristics of patients with heart failure (HF) prescribed vericiguat vs. eligible patients with HF not prescribed vericiguat, and sought to identify factors associated with vericiguat use in real-world settings.MethodsWe analysed 2022–2023 Adelphi HF cross-sectional surv...

Full description

Saved in:
Bibliographic Details
Main Authors: Stephen J. Greene, Catelyn R. Coyle, Lucy N. Hancock, Kathryn W. Tebbs, Sophie G. Barlow, Andra S. Stevenson, Engels N. Obi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
vericiguat
heart failure
eligibility
United States
ejection fraction
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2025.1633435/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2025.1633435/full

Similar Items